Editorial commentary: Host and viral factors in emergent influenza virus infections

Clinical Infectious Diseases

Volumn 58, Issue 8, 2014, Pages 1104-1106

  Hui, David S ^a   Hayden, Frederick G ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

avian influenza; host genetics; influenza; smoking; virulence

Indexed keywords

HOST FACTOR; INFLUENZA VACCINE; SIALIDASE INHIBITOR;

ALLELE; ARTIFICIAL VENTILATION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART DISEASE; HOST; HUMAN; INFLUENZA; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA A (H7N9); NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; FEMALE; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N9; ISOLATION AND PURIFICATION; MALE; PATHOLOGY; VIROLOGY;

FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE;

EID: 84897423883     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu054     Document Type: Note

References (39)

1. Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467-71.
2. Chan PK. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002; 34(suppl 2):S58-64.
3. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection With Avian Influenza A (H5N1) Virus. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008; 358:261-73.
4. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza; Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708-19.
5. World Health Organization. Monthly risk assessment summary. Influenza at the humananimal interface. Available at: http://www. who.int/influenza/human- animal-interface/Influenza-Summary-IRA-HA-interface-20 December13.pdf. Accessed 31 December 2013.
6. Wang C, Yu H, Horby PW, et al. Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis 2014; 58:1095-103.
7. Cowling BJ, Jin L, Lau EH, et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory- -confirmed cases. Lancet 2013; 382:129-37.
8. Yu H, Gao Z, Feng Z, et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 2008; 3:e2985.
9. Liem NT, Tung CV, Hien ND, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009; 48:1639-46.
10. Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a metaanalysis. JAMA 2013; 310:1711-20.
11. Casscells SW, Granger E, Kress AM, et al. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ Cardiovasc Qual Outcomes 2009; 2:108-15.
12. Madjid M, Curkendall S, Blumentals WA. The influence of oseltamivir treatment on the risk of stroke after influenza infection. Cardiology 2009; 113:98-107.
13. Govorkova EA, Ilyushina NA, Boltz DA, et al. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother 2007; 51:1414-24.
14. Chan PK, Lee N, Zaman M, et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis 2012; 206:1359-66.
15. Shrestha SS, Swerdlow DL, Borse RH, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 2011; 52 (suppl 1):S75-82.
16. Simonsen L, Clarke MJ, Schonberger LB, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:53-60.
17. Razani-Boroujerdi S, Singh SP, et al. Chronic nicotine inhibits inflammation and promotes influenza infection. Cell Immunol 2004; 230:1-9.
18. Kark JD, Lebiush M, Rannon L. Cigarette smoking as a risk factor for epidemic a (H1N1) influenza in young men. N Engl J Med 1982; 307:1042-6.
19. Nicholson KG, Kent J, Hammersley V. Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiol Infect 1999; 123:103-8.
20. Murin S, Bilello KS. Respiratory tract infections: another reason not to smoke. Cleve Clin J Med 2005; 72:916-20.
21. CruijffM, Thijs C, GovaertT, et al. The effect of smoking on influenza, influenza vaccination efficacy and on the antibody response to influenza vaccination. Vaccine 1999; 17:426-32.
22. Muscatello DJ, Barr M, Thackway SV, Mac- Intyre CR. Epidemiology of influenza-like illness during pandemic (H1N1) 2009, New South Wales, Australia. Emerging Infectious Diseases 2011; 17:1240-7.
23. Ward KA, Spokes PJ, McAnulty JM. Case- control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. Emerging Infectious Diseases 2011; 17:1409-16.
24. VarnerMW, Rice MM, Anderson B, et al. Influenza- like illness in hospitalized pregnant and postpartum women during the 2009- 2010 H1N1 pandemic. Obstetrics Gynecology 2011; 118:593-600.
25. Feng Y, Kong Y, Barnes PF, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun 2011; 79:229-37.
26. Yageta Y, Ishii Y, Morishima Y, et al. Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice. J Virol 2011; 85:4679-90.
27. Horby P, Nguyen NY, Dunstan SJ, Baillie JK. The role of host genetics in susceptibility to influenza: a systematic review. PLoS One 2012; 7:e33180.
28. Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484: 519-23.
29. Zhang YH, Zhao Y, Li N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 2013; 4:1418.
30. Wang Z, Zhang A, Wan Y, et al. Early hypercytokinemia is associated with interferoninduced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A 2014; 111:769-74.
31. To KK, Zhou J, Song YQ, et al. Surfactant protein B gene polymorphism is associated with severe influenza [Epub ahead of print]. Chest 2013. doi:10.1378/chest.13-1651.
32. Oshansky CM, Roddam PL, et al. HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proc Natl Acad Sci U S A 2013; 110:13492-7.
33. Keynan Y, Juno J, Meyers A, et al. Chemokine receptor 5 ?32allele in patients with severe pandemic (H1N1) 2009. Emerg Infect Dis 2010; 16:1621-2.
34. Horby P, Sudoyo H, Viprakasit V, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect 2010; 138:1550-8.
35. Yang SG, Cao B, Liang LR, et al. Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus. PLoS One 2012; 7:e29652.
36. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013; 381:2273-9.
37. Hui DS, Lee N, Chan PK. Adjunctive therapies and immunomodulatory agents in the management of severe influenza. Antiviral Res 2013; 98:410-6.
38. Chen HY, Yuan H, Gao R, et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 2014. Available at: http://dx.doi.org/10.1016/S0140- 6736(14) 60111-2. Accessed 5 February 2014.
39. WHO Representative Office China. Avian influenza A (H10N8). Available at: http://www. wpro.who.int/china/mediacentre/factsheets/h10n8/en/. Accesssed 5 February 2014.